Huntington National Bank Sells 6,678 Shares of Corteva, Inc. $CTVA

Huntington National Bank decreased its position in Corteva, Inc. (NYSE:CTVA) by 2.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 305,141 shares of the company’s stock after selling 6,678 shares during the period. Huntington National Bank’s holdings in Corteva were worth $20,454,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Activest Wealth Management boosted its holdings in Corteva by 118.3% in the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after acquiring an additional 200 shares during the last quarter. JPL Wealth Management LLC acquired a new stake in shares of Corteva during the third quarter worth $25,000. Redmont Wealth Advisors LLC acquired a new stake in shares of Corteva during the third quarter worth $29,000. Jackson Grant Investment Advisers Inc. grew its stake in shares of Corteva by 90.6% during the third quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock worth $30,000 after purchasing an additional 213 shares during the period. Finally, Measured Wealth Private Client Group LLC acquired a new stake in shares of Corteva during the third quarter worth $33,000. Institutional investors own 81.54% of the company’s stock.

Corteva Trading Up 1.0%

Shares of NYSE:CTVA opened at $79.89 on Thursday. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $85.63. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The company’s fifty day simple moving average is $81.34 and its 200 day simple moving average is $74.39. The firm has a market cap of $53.43 billion, a price-to-earnings ratio of 46.99, a PEG ratio of 2.42 and a beta of 0.59.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.64 billion. During the same quarter last year, the business posted $1.13 EPS. The company’s revenue for the quarter was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, research analysts forecast that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be paid a $0.18 dividend. The ex-dividend date of this dividend is Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is currently 42.35%.

Wall Street Analyst Weigh In

CTVA has been the subject of a number of analyst reports. Wolfe Research lifted their price objective on Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. Citigroup lifted their price objective on Corteva from $83.00 to $85.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. Zacks Research cut Corteva from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 20th. UBS Group lifted their price objective on Corteva from $88.00 to $90.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. Finally, Wells Fargo & Company lifted their price objective on Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 21st. Thirteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $88.14.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.